Merck & Co., Inc.MRKNYSE
Loading
SG&A Expenses Over TimeStable
Percentile Rank71
3Y CAGR+3.1%
5Y CAGR+4.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+3.1%/yr
vs -1.1%/yr prior
5Y CAGR
+4.4%/yr
Consistent
Acceleration
+4.2pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
5 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.61B | +5.0% |
| 2024 | $10.10B | +2.2% |
| 2023 | $9.88B | +2.2% |
| 2022 | $9.67B | +2.8% |
| 2021 | $9.40B | +9.7% |
| 2020 | $8.57B | -9.4% |
| 2019 | $9.46B | -6.4% |
| 2018 | $10.10B | +0.3% |
| 2017 | $10.07B | +0.6% |
| 2016 | $10.02B | - |